4.2 Review

Impact of COVID-19 on management of urogynaecology patients: a rapid review of the literature

Journal

INTERNATIONAL UROGYNECOLOGY JOURNAL
Volume 32, Issue 10, Pages 2631-2646

Publisher

SPRINGER LONDON LTD
DOI: 10.1007/s00192-021-04704-2

Keywords

Coronavirus; COVID-19; Surgical prioritisation; Telemedicine; Urogynaecology

Funding

  1. Contura

Ask authors/readers for more resources

This rapid review provides evidence synthesis on the current recommendations for urogynaecological care during the COVID-19 pandemic, including virtual clinics, deferring certain investigations and surgeries, and lack of evidence for a specific surgical approach while emphasizing minimizing COVID-19 transmission.
Introduction and hypothesis The coronavirus (COVID-19) pandemic has impacted health systems worldwide. There is a continuing need for clinicians to adapt practice to facilitate timely provision of medical care, whilst minimising horizontal transmission. Guidance and recommendations are increasingly available, and this rapid review aimed to provide a timely evidence synthesis on the current recommendations surrounding urogynaecological care. Methods We performed a literature review using PubMed/Medline, Embase and Cochrane and a manual search of national and international societies for management recommendations for urogynaecological patients during the COVID-19 pandemic. Results Nine guidance documents and 17 articles, including 10 reviews, were included. Virtual clinics are recommended for new and follow-up patients, to assess and initiate treatment, as well as triage patients who require face-to-face appointments. Outpatient investigations such as urodynamics and cystoscopy for benign indications can be deferred. Prolapse and continence surgery should be suspended, except in specific circumstances such as procidentia with upper tract complications and failed pessaries. There is no evidence to support a particular route of surgery, but recommendations are made to minimise COVID-19 transmission. Conclusions Urogynaecological patients face particular challenges owing to inherent vulnerabilities of these populations. Behavioural and medical therapies should be recommended as first line options and initiated via virtual or remote clinics, which are integral to management during the COVID-19 pandemic. Expanding the availability and accessibility of technology will be increasingly required. The majority of outpatient and inpatient procedures can be deferred, but the longer-term effects of such practices are unclear.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available